M Volm - JoVE Visualize

Showing results (221-230 of 238) with videos related to

Pageof 24

Sort By:

American Journal of Obstetrics and Gynecology|March 1, 1992

Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissueJ Schneider, T Efferth, J Mattern, et al.

International Journal of Cancer|November 14, 1997

Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemiaM Volm, R Koomägi, G Stammler, et al.

British Journal of Cancer|December 1, 1989

P-glycoprotein expression in treated and untreated human breast cancerJ Schneider, M Bak, T Efferth, et al.

European Journal of Biochemistry|January 1, 1980

Competing pathways in the formation of alkyl, alk-1-enyl and acyl moieties in the lipids of mammalian tissuesK D Mukherjee, N Weber, H K Mangold, et al.

Anticancer Research|September 1, 1986

Relevance of DNA-fluorimetry and short-term resistance testing for adjuvant treatment of non-small cell lung carcinomasM Volm, P Drings, J Mattern, et al.

Cancer Research|October 1, 1985

Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinomaM Volm, A Brüggemann, M Günther, et al.

Cancer|September 15, 1985

Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinomaM Volm, P Drings, J Mattern, et al.

Zeitschrift Fur Naturforschung. Section C, Biosciences|September 1, 1979

Radioactive labelling of lipids in rat neurosarcoma by intravenous injection of [1-14C]-octadecenolN Weber, M Volm, K Wayss, et al.

Anticancer Research|July 1, 1993

Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788T Efferth, T A Dunn, M Berlion, et al.

Cancer Research|May 15, 1988

Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinomaM Volm, E W Hahn, J Mattern, et al.

Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:

Pageof 24

American Journal of Obstetrics and Gynecology|March 1, 1992

Immunohistochemical detection of the multi-drug-resistance marker P-glycoprotein in uterine cervical carcinomas and normal cervical tissueJ Schneider, T Efferth, J Mattern, et al.

International Journal of Cancer|November 14, 1997

Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemiaM Volm, R Koomägi, G Stammler, et al.

British Journal of Cancer|December 1, 1989

P-glycoprotein expression in treated and untreated human breast cancerJ Schneider, M Bak, T Efferth, et al.

European Journal of Biochemistry|January 1, 1980

Competing pathways in the formation of alkyl, alk-1-enyl and acyl moieties in the lipids of mammalian tissuesK D Mukherjee, N Weber, H K Mangold, et al.

Anticancer Research|September 1, 1986

Relevance of DNA-fluorimetry and short-term resistance testing for adjuvant treatment of non-small cell lung carcinomasM Volm, P Drings, J Mattern, et al.

Cancer Research|October 1, 1985

Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinomaM Volm, A Brüggemann, M Günther, et al.

Cancer|September 15, 1985

Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinomaM Volm, P Drings, J Mattern, et al.

Zeitschrift Fur Naturforschung. Section C, Biosciences|September 1, 1979

Radioactive labelling of lipids in rat neurosarcoma by intravenous injection of [1-14C]-octadecenolN Weber, M Volm, K Wayss, et al.

Anticancer Research|July 1, 1993

Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788T Efferth, T A Dunn, M Berlion, et al.

Cancer Research|May 15, 1988

Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinomaM Volm, E W Hahn, J Mattern, et al.

Pageof 24